Response to Dr.Tayebi Meybodi\'s letter

Authors

  • Mehdi Zeinalizadeh Department of Neurological Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Zahid Hussain Khan Department of Anesthesiology & Critical Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Response to Letter by

Response: While our work passed through the peer-review process for publication in Stroke, Pilz et al published data demonstrating an inverse and independent correlation between adiponectin levels and carotid intima-media thickness (IMT).1 In this work, the authors compared 140 obese juveniles (mean age 13.5 4.4 years) with 100 age-matched, healthy, normal-weight controls and demonstrated a sig...

full text

Response to Letter

W e thank the authors for reporting an unexpected clustering of Caucasian patients with the Val142Ile (more commonly known as Val122Ile) mutation. These interesting findings further emphasize the importance of genetic counseling and clinical genetic testing in patients with TTR cardiac amyloidosis.commercial use, distribution, and reproduction in any medium, provided the original work is proper...

full text

Response to Letter

W e thank Dr. Rasmussen for his recent letter expressing concerns about statements made in our article with regard to the efficacy of sodium zirconium cyclosilicate (ZS-9) in patients with serum potassium (K ) concentrations 6.5 mEq/L. Although ZS-9 is certainly one of the potential agents for the treatment of acute hyperkalemia in the future, the HARMONIZE trial (1) was conducted in an outpati...

full text

Response to Letter.

We would like to thank M. Korppi for his correspondence regarding our article. In the prospective, randomized, double-blind, controlled study, we enrolled 39 infants suffering from bronchiolitis, therefore analyzing the effect of 7% hypertonic saline—0.1% hyaluronic acid (7% HS– HA) on the clinical course of the disease. We agreewithM.Korppi that the evidence of the length of hospital stay (LOS...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue None

pages  16- 17

publication date 2021-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023